Fig. 1From: Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injuryBilateral adhesive removal test. Mean (+SEM) time to contact the contralateral adhesive in sham-vehicle (n = 9), TBI-vehicle (n = 10), sham-EFX (n = 10), and TBI-EFX (n = 8) groups. EFX treatment significantly improved the time to contact on day 2 post-CCI compared with vehicle treatment in TBI animals (## p < 0.01). ***p < 0.001 compared to pre-TBI; ### p < 0.001 and ## p < 0.01 compared to TBI-vehicleBack to article page